Picomole Aiming for 2024 Launch

With a major funding round in its sights this year, Moncton-based medtech company Picomole is aiming to have a product on the market in 2024 that can detect lung cancer from a single breath sample.
The technology has been in development for about a decade, and the company got a major boost from a $6.5 million funding round in 2019. Now the 22-member team is developing the product in preparation